tiprankstipranks
Trending News
More News >
IntegraGen SA (FR:ALINT)
:ALINT
France Market

IntegraGen SA (ALINT) Price & Analysis

Compare
0 Followers

ALINT Stock Chart & Stats


Financials

ALINT FAQ

What was IntegraGen SA’s price range in the past 12 months?
IntegraGen SA lowest stock price was €0.23 and its highest was €0.86 in the past 12 months.
    What is IntegraGen SA’s market cap?
    IntegraGen SA’s market cap is €1.69M.
      When is IntegraGen SA’s upcoming earnings report date?
      IntegraGen SA’s upcoming earnings report date is Oct 16, 2025 which is in 98 days.
        How were IntegraGen SA’s earnings last quarter?
        IntegraGen SA released its earnings results on Apr 29, 2025. The company reported -€0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.021.
          Is IntegraGen SA overvalued?
          According to Wall Street analysts IntegraGen SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does IntegraGen SA pay dividends?
            IntegraGen SA does not currently pay dividends.
            What is IntegraGen SA’s EPS estimate?
            IntegraGen SA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does IntegraGen SA have?
            IntegraGen SA has 6,727,332 shares outstanding.
              What happened to IntegraGen SA’s price movement after its last earnings report?
              IntegraGen SA reported an EPS of -€0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.852%.
                Which hedge fund is a major shareholder of IntegraGen SA?
                Currently, no hedge funds are holding shares in FR:ALINT

                Company Description

                IntegraGen SA

                IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
                Similar Stocks
                Company
                Price & Change
                Follow
                Quantum Genomics
                Hybrigenics SA Class A
                Biophytis SA
                Theranexus SA
                Neovacs SA
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis